Advocacy Group Launches National Campaign to Reform 340B Drug Pricing Program
ADAP Advocacy initiates a nationwide campaign questioning the accountability and transparency of the 340B Drug Pricing Program, drawing parallels to pre-2008 financial market oversight and highlighting potential systemic issues in healthcare.
